GlaxoSmithKline Nigeria Plc released its financial results for nine months ended September 2015.
The result showed that revenue declined by 24.51% from N30.5 billion in Q3’2014 to N23 billion in Q3’2015.
Profit before tax also declined by 74.51% from N2.7 billion in Q3’2014 to N700 million in Q3’2015.
See Summary of result below..
GlaxoSmithkline Nigeria Plc Q3 2015 | 2015 | 2014 | % Change |
N’m | N’m | ||
Revenue | 23,040 | 30,521 | -24.51% |
Gross Profit | 7,407 | 10,735 | -31.00% |
Operating Expenses | -2,511 | -3,039 | -17.37% |
Pre-tax profits | 700 | 2,752 | -74.56% |
Profit After Tax | 485 | 1,848 | -73.76% |
Share Price (As at Press time) | Â 38.20 |